These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 12072104

  • 1. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M.
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [Abstract] [Full Text] [Related]

  • 2. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S, Alavian SM, Hajarizadeh B.
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM, Tabatabaei SV.
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [Abstract] [Full Text] [Related]

  • 4. Effect of adding levamisole on seroconversion response to hepatitis B virus vaccination in hemodialysis patients: a single-center experience.
    Sanadgol H, Khoshnoodi M, Mashhadi MA, Forghani MS.
    Iran J Kidney Dis; 2011 Sep; 5(5):338-41. PubMed ID: 21876312
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial.
    Hosseini M, Shalchiantabrizi P, Dadgarmoghaddam M, Ahmady-Simab S, Behjati A, Salari M.
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):219-227. PubMed ID: 28732435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K, al-Mufti S, Johny KV, Sugathan TN.
    Vaccine; 1994 Sep; 12(3):223-34. PubMed ID: 8165854
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
    Vaccine; 2011 Dec 06; 29(52):9618-23. PubMed ID: 22044739
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M, Acar K, Sucak GT, Yamaç K, Haznedar R.
    Eur J Haematol; 2007 Oct 06; 79(4):292-6. PubMed ID: 17655695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP, Mandal SK, Thakur A, Kapoor D, Anuradha S, Prakash A, Kohli R, Agarwal SK.
    Ren Fail; 2003 Mar 06; 25(2):255-66. PubMed ID: 12739832
    [Abstract] [Full Text] [Related]

  • 16. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.
    Grzegorzewska AE, Wobszal PM, Sowińska A, Mostowska A, Jagodziński PP.
    Mol Biol Rep; 2013 Dec 06; 40(12):6899-911. PubMed ID: 24158609
    [Abstract] [Full Text] [Related]

  • 17. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J.
    Am J Nephrol; 1996 Dec 06; 16(2):95-7. PubMed ID: 8919223
    [Abstract] [Full Text] [Related]

  • 18. [New vaccination protocol against hepatitis B for hemodialysis patients--a single-centre experience].
    Resić H, Kukavica N, Masnić F, Prohić N, Sahović V, Ajanović S, Corić A, Avdić E, Helać-Cvijetić D.
    Acta Med Croatica; 2011 Dec 06; 65(5):405-14. PubMed ID: 22994011
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK.
    J Viral Hepat; 1999 Sep 06; 6(5):405-9. PubMed ID: 10607257
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A, Demirhan H, Sorkun HÇ, Özkan S, Aydın M, Akın D, Tatar B, Çatak B, Şener A, Köse Ş.
    Int Urol Nephrol; 2017 Oct 06; 49(10):1845-1850. PubMed ID: 28620716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.